Advanced Cancer

Showing NaN - NaN of 40

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Cancer Trial in Worldwide (Nivolumab, Dasatinib, Relatlimab)

Terminated
  • Advanced Cancer
  • Nivolumab
  • +4 more
  • Duarte, California
  • +49 more
Feb 23, 2021

Advanced Cancer, Solid Tumors Trial in Boston, Nashville (NEV801)

Recruiting
  • Advanced Cancer
  • Solid Tumors
  • Boston, Massachusetts
  • +1 more
Mar 2, 2021

Advanced Cancer Trial in Boston (video decision aid)

Unknown status
  • Advanced Cancer
  • video decision aid
  • Boston, Massachusetts
    Massachusetts General Hospital
Nov 16, 2020

Advanced Cancer Trial in Korea, Republic of, United States (MGCD516)

Unknown status
  • Advanced Cancer
  • Birmingham, Alabama
  • +42 more
Jan 28, 2020

Advanced Cancer, Advanced Malignancies Trial in Australia, Spain, United States (Cemiplimab, Hypofractionated radiotherapy,

Completed
  • Advanced Cancer
  • Advanced Malignancies
  • Gilbert, Arizona
  • +46 more
Jan 23, 2020

Advanced Cancer Trial in Boston, Portland, Nashville (CDX-0158 (formerly known as KTN-0158))

Completed
  • Advanced Cancer
  • CDX-0158 (formerly known as KTN-0158)
  • Boston, Massachusetts
  • +3 more
Jun 11, 2019

Advanced Cancer Trial in Canada, Korea, Republic of, United States (MGCD265)

Completed
  • Advanced Cancer
  • Duarte, California
  • +18 more
Feb 11, 2019

Advanced Cancer Trial in United States (LY2875358, LY2875358 + erlotinib, LY2875358 at Part A highest dose)

Completed
  • Advanced Cancer
  • La Jolla, California
  • +9 more
Feb 14, 2017

Advanced Cancer Trial in Aurora, Boston (ENMD-2076)

Completed
  • Advanced Cancer
  • Aurora, Colorado
  • +1 more
Jan 26, 2016

Advanced Cancer Trial in Canada, United States (Capecitabine, Doxorubicin, Ixabepilone)

Completed
  • Advanced Cancer
  • Los Angeles, California
  • +4 more
Jul 3, 2015

Advanced Cancer Trial in Sarasota, Boston, Nashville (OPB-51602)

Completed
  • Advanced Cancer
  • Sarasota, Florida
  • +2 more
Jan 14, 2014

Advanced Cancer, Pancreatic Cancer Trial in United States (ARRY-334543, EGFR/ErbB2 inhibitor; oral, Gemcitabine, nucleoside

Completed
  • Advanced Cancer
  • Pancreatic Cancer
  • ARRY-334543, EGFR/ErbB2 inhibitor; oral
  • Gemcitabine, nucleoside analogue; intravenous
  • Phoenix, Arizona
  • +5 more
Sep 28, 2012

Advanced Cancer Trial in Boston (video decision aid)

Completed
  • Advanced Cancer
  • video decision aid
  • Boston, Massachusetts
    Massachusetts General Hospital
Jul 9, 2012

Advanced Cancer, Refractory Cancer Trial in United States (AV-412)

Completed
  • Advanced Cancer
  • Refractory Cancer
  • Washington, District of Columbia
  • +3 more
Sep 30, 2011